These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29955492)

  • 1. Valproate serum concentrations in patients with hypoalbuminemia and medical complications.
    VandenBerg A; Broadway J; Lalich C; Kennedy R; Williams K
    Ment Health Clin; 2017 Jan; 7(1):13-15. PubMed ID: 29955492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Serum-Free and Cerebrospinal Fluid Valproic Acid Levels in Patients With Hypoalbuminemia After Craniotomy.
    Li Z; Gao W; Liu G; Chen W
    Ther Drug Monit; 2020 Aug; 42(4):610-616. PubMed ID: 32106182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Importance of Monitoring Unbound Valproic Acid Concentration in Patients with Hypoalbuminemia.
    Doré M; San Juan AE; Frenette AJ; Williamson D
    Pharmacotherapy; 2017 Aug; 37(8):900-907. PubMed ID: 28574586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated free fractions of valproic acid in a heart transplant patient with hypoalbuminemia.
    Haroldson JA; Kramer LE; Wolff DL; Lake KD
    Ann Pharmacother; 2000 Feb; 34(2):183-7. PubMed ID: 10676827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Valproic Acid Concentration Correction Based on Serum Albumin.
    Drisaldi A; Weeda E; Neyens R; Orvin N; Bonilha L; Campbell Z; Bohm N
    Neurocrit Care; 2019 Apr; 30(2):301-306. PubMed ID: 30328046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient decrease in serum albumin concentrations in epileptic children treated with sodium valproate monotherapy.
    Attilakos A; Voudris KA; Katsarou E; Prassouli A; Mastroyianni S; Garoufi A
    Clin Neuropharmacol; 2007; 30(3):145-9. PubMed ID: 17545749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of valproate coadministration and hypoalbuminemia on the serum-free phenytoin concentration in patients with severe motor and intellectual disabilities.
    Mamiya K; Yukawa E; Matsumoto T; Aita C; Goto S
    Clin Neuropharmacol; 2002; 25(4):230-3. PubMed ID: 12151911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case report on reversible Pelger-Huët anomaly depending on serum free fraction of valproic acid.
    Suzuki K; Hiramoto A; Okumura T
    Brain Dev; 2015 Mar; 37(3):344-6. PubMed ID: 24985021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A theoretical method for normalizing total serum valproic acid concentration in hypoalbuminemic patients.
    Hermida J; Tutor JC
    J Pharmacol Sci; 2005 Apr; 97(4):489-93. PubMed ID: 15840952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review.
    Lin K; Cao VFS; Au C; Dahri K
    Clin Pharmacokinet; 2022 Oct; 61(10):1345-1363. PubMed ID: 36040614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring for valproate and phenytoin toxicity in hypoalbuminaemia: A retrospective cohort study.
    Madan A; Donovan PJ; Risetto T; Trenerry H; Lander CM
    Br J Clin Pharmacol; 2021 Nov; 87(11):4341-4353. PubMed ID: 33835518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproate Protein Binding Is Highly Variable in ICU Patients and Not Predicted by Total Serum Concentrations: A Case Series and Literature Review.
    Riker RR; Gagnon DJ; Hatton C; May T; Seder DB; Stokem K; Fraser GL
    Pharmacotherapy; 2017 Apr; 37(4):500-508. PubMed ID: 28173638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of free serum valproate concentration: A prospective study in patients on divalproex sodium monotherapy.
    Nasreddine W; Dirani M; Atweh S; Makki A; Beydoun A
    Seizure; 2018 Jul; 59():24-27. PubMed ID: 29730272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoalbuminemia with valproic acid administration.
    Rugino TA; Janvier YM; Baunach JM; Bilat CA
    Pediatr Neurol; 2003 Nov; 29(5):440-4. PubMed ID: 14684241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate protein binding following rapid intravenous administration of high doses of valproic acid in patients with epilepsy.
    Dutta S; Faught E; Limdi NA
    J Clin Pharm Ther; 2007 Aug; 32(4):365-71. PubMed ID: 17635338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated free phenytoin and free valproic acid concentrations in sera of patients infected with human immunodeficiency virus.
    Dasgupta A; McLemore JL
    Ther Drug Monit; 1998 Feb; 20(1):63-7. PubMed ID: 9485557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy.
    Cloyd JC; Dutta S; Cao G; Walch JK; Collins SD; Granneman GR;
    Epilepsy Res; 2003 Feb; 53(1-2):19-27. PubMed ID: 12576164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro changes in the proportion of protein-unbound-free propofol induced by valproate.
    Ishii-Maruhama M; Higuchi H; Nakanou M; Honda-Wakasugi Y; Yabuki-Kawase A; Maeda S; Miyawaki T
    J Anesth; 2018 Oct; 32(5):688-693. PubMed ID: 30062394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.
    de Maat MM; van Leeuwen HJ; Edelbroek PM
    Ann Pharmacother; 2011 Mar; 45(3):e18. PubMed ID: 21325101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.